Lonza Group - Financing for proposed acquisition of Arch Chemicals

  • 11 July 2011
 

Slaughter and May is acting for Lonza, one of the world's leading suppliers to the pharmaceutical, healthcare and life science industries, on the financing of its proposed acquisition of Arch Chemicals, a global biocides company listed on the NYSE.

Lonza's tender offer, which was announced on 11 July 2011, will be fully debt financed and values Arch Chemicals at approximately USD 1,400,000,000.

Jenner & Block LLP is advising Lonza on matters of US law.

 
 

Contacts

 

Robert Byk (partner), Andrew McClean (partner), Tom Vickers (associate)

 
List of all recent work 
 

Related practice areas